Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized Recombinant Human IL-4 Receptor in Asthma
NCT00017693Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 1998
- Primary completion
- Feb 2000
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of Altrakincept in asthma, sponsored by National Institute of Allergy and Infectious Diseases. Started May 1998; status: completed.
02
Drugs
Altrakincept
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00017693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017693.